{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:16:02Z","timestamp":1790835362795,"version":"4.1.0"},"reference-count":106,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2017.01590","type":"journal-article","created":{"date-parts":[[2017,11,20]],"date-time":"2017-11-20T09:25:29Z","timestamp":1511169929000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":71,"title":["Non-Neutralizing Antibodies Directed against HIV and Their Functions"],"prefix":"10.3389","volume":"8","author":[{"given":"Luzia M.","family":"Mayr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"Moog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2017,11,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/imr.12517","article-title":"The quest for an antibody-based HIV vaccine","volume":"275","author":"Haynes","year":"2017","journal-title":"Immunol Rev"},{"key":"B2","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/imr.12502","article-title":"B-cell responses to HIV infection","volume":"275","author":"Moir","year":"2017","journal-title":"Immunol Rev"},{"key":"B3","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.imlet.2014.10.011","article-title":"The activation of the adaptive immune system: cross-talk between antigen-presenting cells, T cells and B cells","volume":"162","author":"den Haan","year":"2014","journal-title":"Immunol Lett"},{"key":"B4","doi-asserted-by":"publisher","first-page":"6177","DOI":"10.1128\/JVI.02625-05","article-title":"Nonneutralizing antibodies are able to inhibit human immunodeficiency virus type 1 replication in macrophages and immature dendritic cells","volume":"80","author":"Holl","year":"2006","journal-title":"J Virol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1097\/COH.0000000000000357","article-title":"Role of nonneutralizing antibodies in vaccines and\/or HIV infected individuals","volume":"12","author":"Mayr","year":"2017","journal-title":"Curr Opin HIV AIDS"},{"key":"B6","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1146\/annurev-immunol-051116-052433","article-title":"Anti-retroviral antibody FcgammaR-mediated effector functions","volume":"275","author":"Bournazos","year":"2017","journal-title":"Immunol Rev"},{"key":"B7","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1089\/AID.2016.0299","article-title":"Beyond viral neutralization","volume":"33","author":"Lewis","year":"2017","journal-title":"AIDS Res Hum Retroviruses"},{"key":"B8","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1111\/imr.12510","article-title":"Survivors remorse: antibody-mediated protection against HIV-1","volume":"275","author":"Lewis","year":"2017","journal-title":"Immunol Rev"},{"key":"B9","doi-asserted-by":"publisher","first-page":"780","DOI":"10.3389\/fimmu.2017.00780","article-title":"Antiviral functions of human immunodeficiency virus type 1 (HIV-1)-specific IgG antibodies: effects of antiretroviral therapy and implications for therapeutic HIV-1 vaccine design","volume":"8","author":"French","year":"2017","journal-title":"Front Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"289","DOI":"10.3389\/fimmu.2014.00289","article-title":"Which antibody functions are important for an HIV vaccine?","volume":"5","author":"Su","year":"2014","journal-title":"Front Immunol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.3390\/v1031265","article-title":"Antibody-mediated Fcgamma receptor-based mechanisms of HIV inhibition: recent findings and new vaccination strategies","volume":"1","author":"Holl","year":"2009","journal-title":"Viruses"},{"key":"B12","doi-asserted-by":"publisher","first-page":"11604","DOI":"10.1128\/JVI.01361-13","article-title":"Neutralizing IgG at the portal of infection mediates protection against vaginal simian\/human immunodeficiency virus challenge","volume":"87","author":"Klein","year":"2013","journal-title":"J Virol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nature06106","article-title":"Fc receptor but not complement binding is important in antibody protection against HIV","volume":"449","author":"Hessell","year":"2007","journal-title":"Nature"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1126\/science.aag0491","article-title":"Antibody-mediated protection against SHIV challenge includes systemic clearance of distal virus","volume":"353","author":"Liu","year":"2016","journal-title":"Science"},{"key":"B15","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/nm.4063","article-title":"Early short-term treatment with neutralizing human monoclonal antibodies halts SHIV infection in infant macaques","volume":"22","author":"Hessell","year":"2016","journal-title":"Nat Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"e87572","DOI":"10.1371\/journal.pone.0087572","article-title":"Vaccine-induced IgG antibodies to V1V2 regions of multiple HIV-1 subtypes correlate with decreased risk of HIV-1 infection","volume":"9","author":"Zolla-Pazner","year":"2014","journal-title":"PLoS One"},{"key":"B17","doi-asserted-by":"publisher","first-page":"9019","DOI":"10.1073\/pnas.1301456110","article-title":"Vaccine-induced plasma IgA specific for the C1 region of the HIV-1 envelope blocks binding and effector function of IgG","volume":"110","author":"Tomaras","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1056\/NEJMoa1113425","article-title":"Immune-correlates analysis of an HIV-1 vaccine efficacy trial","volume":"366","author":"Haynes","year":"2012","journal-title":"N Engl J Med"},{"key":"B19","doi-asserted-by":"publisher","first-page":"11521","DOI":"10.1128\/JVI.01023-12","article-title":"Antibody-dependent cellular cytotoxicity-mediating antibodies from an HIV-1 vaccine efficacy trial target multiple epitopes and preferentially use the VH1 gene family","volume":"86","author":"Bonsignori","year":"2012","journal-title":"J Virol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e1005042","DOI":"10.1371\/journal.ppat.1005042","article-title":"Human non-neutralizing HIV-1 envelope monoclonal antibodies limit the number of founder viruses during SHIV mucosal infection in rhesus macaques","volume":"11","author":"Santra","year":"2015","journal-title":"PLoS Pathog"},{"key":"B21","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/mi.2013.23","article-title":"Protective effect of vaginal application of neutralizing and nonneutralizing inhibitory antibodies against vaginal SHIV challenge in macaques","volume":"7","author":"Moog","year":"2014","journal-title":"Mucosal Immunol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"5115","DOI":"10.3390\/v7092856","article-title":"Conformational masking and receptor-dependent unmasking of highly conserved Env epitopes recognized by non-neutralizing antibodies that mediate potent ADCC against HIV-1","volume":"7","author":"Lewis","year":"2015","journal-title":"Viruses"},{"key":"B23","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.cell.2017.06.048","article-title":"Non-neutralizing antibodies alter the course of HIV-1 infection in vivo","volume":"170","author":"Horwitz","year":"2017","journal-title":"Cell"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1038\/mi.2016.8","article-title":"Enhanced binding of antibodies generated during chronic HIV infection to mucus component MUC16","volume":"9","author":"Gunn","year":"2016","journal-title":"Mucosal Immunol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1172\/JCI84428","article-title":"Broadly neutralizing anti-influenza antibodies require Fc receptor engagement for in vivo protection","volume":"126","author":"DiLillo","year":"2016","journal-title":"J Clin Invest"},{"key":"B26","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/imr.12484","article-title":"Identification and specificity of broadly neutralizing antibodies against HIV","volume":"275","author":"McCoy","year":"2017","journal-title":"Immunol Rev"},{"key":"B27","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1111\/imr.12480","article-title":"Antibodyomics: bioinformatics technologies for understanding B-cell immunity to HIV-1","volume":"275","author":"Kwong","year":"2017","journal-title":"Immunol Rev"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1089\/AID.2015.0050","article-title":"Short communication: virion aggregation by neutralizing and nonneutralizing antibodies to the HIV-1 envelope glycoprotein","volume":"31","author":"Alexander","year":"2015","journal-title":"AIDS Res Hum Retroviruses"},{"key":"B29","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s12977-014-0078-8","article-title":"Aggregate complexes of HIV-1 induced by multimeric antibodies","volume":"11","author":"Stieh","year":"2014","journal-title":"Retrovirology"},{"key":"B30","doi-asserted-by":"publisher","first-page":"F13","DOI":"10.1097\/QAD.0b013e328360eac6","article-title":"Anti-HIV IgA isotypes: differential virion capture and inhibition of transcytosis are linked to prevention of mucosal R5 SHIV transmission","volume":"27","author":"Watkins","year":"2013","journal-title":"AIDS"},{"key":"B31","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1186\/1742-4690-9-S2-P319","article-title":"Development of an imaging based virus aggregation assay for vaccine development","volume":"9","author":"Stieh","year":"2012","journal-title":"Retrovirology"},{"key":"B32","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1099\/0022-1317-83-9-2091","article-title":"Occupancy and mechanism in antibody-mediated neutralization of animal viruses","volume":"83","author":"Klasse","year":"2002","journal-title":"J Gen Virol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"7397","DOI":"10.1128\/JVI.00656-09","article-title":"Utilization of immunoglobulin G Fc receptors by human immunodeficiency virus type 1: a specific role for antibodies against the membrane-proximal external region of gp41","volume":"83","author":"Perez","year":"2009","journal-title":"J Virol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"e76176","DOI":"10.1371\/journal.pone.0076176","article-title":"Differential binding of IgG and IgA to mucus of the female reproductive tract","volume":"8","author":"Fahrbach","year":"2013","journal-title":"PLoS One"},{"key":"B35","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.immuni.2017.07.009","article-title":"Fcgamma receptor function and the design of vaccination strategies","volume":"47","author":"Bournazos","year":"2017","journal-title":"Immunity"},{"key":"B36","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1111\/imr.12339","article-title":"The role of Fc receptors in HIV prevention and therapy","volume":"268","author":"Boesch","year":"2015","journal-title":"Immunol Rev"},{"key":"B37","doi-asserted-by":"publisher","first-page":"674","DOI":"10.3389\/fimmu.2014.00674","article-title":"Immunomodulation by IVIg and the role of Fc-gamma receptors: classic mechanisms of action after all?","volume":"5","author":"Nagelkerke","year":"2014","journal-title":"Front Immunol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"520","DOI":"10.3389\/fimmu.2014.00520","article-title":"IgG subclasses and allotypes: from structure to effector functions","volume":"5","author":"Vidarsson","year":"2014","journal-title":"Front Immunol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"3716","DOI":"10.1182\/blood-2008-09-179754","article-title":"Specificity and affinity of human Fcgamma receptors and their polymorphic variants for human IgG subclasses","volume":"113","author":"Bruhns","year":"2009","journal-title":"Blood"},{"key":"B40","doi-asserted-by":"publisher","first-page":"7916","DOI":"10.4049\/jimmunol.179.11.7916","article-title":"FcgammaRIIa genotype predicts progression of HIV infection","volume":"179","author":"Forthal","year":"2007","journal-title":"J Immunol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"3879","DOI":"10.1172\/JCI75539","article-title":"FCGR2C polymorphisms associate with HIV-1 vaccine protection in RV144 trial","volume":"124","author":"Li","year":"2014","journal-title":"J Clin Invest"},{"key":"B42","doi-asserted-by":"publisher","first-page":"334","DOI":"10.4049\/jimmunol.1102175","article-title":"Deciphering the pathways of death of Histoplasma capsulatum-infected macrophages: implications for the immunopathogenesis of early infection","volume":"188","author":"Deepe","year":"2012","journal-title":"J Immunol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"e1005101","DOI":"10.1371\/journal.ppat.1005101","article-title":"Mucosal B cells are associated with delayed SIV acquisition in vaccinated female but not male rhesus macaques following SIVmac251 rectal challenge","volume":"11","author":"Tuero","year":"2015","journal-title":"PLoS Pathog"},{"key":"B44","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1126\/science.aab3886","article-title":"Protective efficacy of adenovirus\/protein vaccines against SIV challenges in rhesus monkeys","volume":"349","author":"Barouch","year":"2015","journal-title":"Science"},{"key":"B45","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.cell.2013.09.061","article-title":"Protective efficacy of a global HIV-1 mosaic vaccine against heterologous SHIV challenges in rhesus monkeys","volume":"155","author":"Barouch","year":"2013","journal-title":"Cell"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1038\/mi.2016.12","article-title":"Fc receptor-mediated phagocytosis in tissues as a potent mechanism for preventive and therapeutic HIV vaccine strategies","volume":"9","author":"Sips","year":"2016","journal-title":"Mucosal Immunol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"5468","DOI":"10.1128\/JVI.03403-12","article-title":"Enhanced phagocytic activity of HIV-specific antibodies correlates with natural production of immunoglobulins with skewed affinity for FcgammaR2a and FcgammaR2b","volume":"87","author":"Ackerman","year":"2013","journal-title":"J Virol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1182\/blood-2009-10-248609","article-title":"Long-lasting antitumor protection by anti-CD20 antibody through cellular immune response","volume":"116","author":"Abes","year":"2010","journal-title":"Blood"},{"key":"B49","doi-asserted-by":"publisher","first-page":"e955684","DOI":"10.4161\/21624011.2014.955684","article-title":"Tumor antigen-targeting monoclonal antibody-based immunotherapy: orchestrating combined strategies for the development of long-term antitumor immunity","volume":"3","author":"Michaud","year":"2014","journal-title":"Oncoimmunology"},{"key":"B50","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1111\/j.1600-065X.2010.00910.x","article-title":"Antibody-mediated modulation of immune responses","volume":"236","author":"Nimmerjahn","year":"2010","journal-title":"Immunol Rev"},{"key":"B51","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1084\/jem.189.2.371","article-title":"Fcgamma receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization","volume":"189","author":"Regnault","year":"1999","journal-title":"J Exp Med"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1089\/AID.2015.0041","article-title":"Short communication: exploring antibody potential as prophylactic\/therapeutic strategies for prevention of early mucosal HIV-1 infection","volume":"31","author":"Su","year":"2015","journal-title":"AIDS Res Hum Retroviruses"},{"key":"B53","doi-asserted-by":"publisher","first-page":"10975","DOI":"10.1128\/JVI.01748-14","article-title":"Broadly neutralizing antibody VRC01 prevents HIV-1 transmission from plasmacytoid dendritic cells to CD4 T lymphocytes","volume":"88","author":"Su","year":"2014","journal-title":"J Virol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"3708","DOI":"10.1182\/blood-2012-03-418913","article-title":"Neutralizing antibodies inhibit HIV-1 transfer from primary dendritic cells to autologous CD4 T lymphocytes","volume":"120","author":"Su","year":"2012","journal-title":"Blood"},{"key":"B55","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/nature12744","article-title":"Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys","volume":"503","author":"Barouch","year":"2013","journal-title":"Nature"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1038\/nm.2233","article-title":"Passive neutralizing antibody controls SHIV viremia and enhances B cell responses in infant macaques","volume":"16","author":"Ng","year":"2010","journal-title":"Nat Med"},{"key":"B57","doi-asserted-by":"publisher","first-page":"e18207","DOI":"10.1371\/journal.pone.0018207","article-title":"An anti-HIV-1 V3 loop antibody fully protects cross-clade and elicits T-cell immunity in macaques mucosally challenged with an R5 clade C SHIV","volume":"6","author":"Watkins","year":"2011","journal-title":"PLoS One"},{"key":"B58","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1126\/science.aaf0972","article-title":"HIV-1 therapy with monoclonal antibody 3BNC117 elicits host immune responses against HIV-1","volume":"352","author":"Schoofs","year":"2016","journal-title":"Science"},{"key":"B59","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/bs.aivir.2016.03.001","article-title":"Cell-to-cell spread of HIV and viral pathogenesis","volume":"95","author":"Law","year":"2016","journal-title":"Adv Virus Res"},{"key":"B60","doi-asserted-by":"publisher","first-page":"65","DOI":"10.2174\/138945011701151217105638","article-title":"HIV-1 cell-to-cell transmission and antiviral strategies: an overview","volume":"17","author":"Casartelli","year":"2016","journal-title":"Curr Drug Targets"},{"key":"B61","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.tim.2015.02.003","article-title":"HIV cell-to-cell transmission: effects on pathogenesis and antiretroviral therapy","volume":"23","author":"Agosto","year":"2015","journal-title":"Trends Microbiol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"e2425","DOI":"10.1128\/JVI.02425-16","article-title":"Reduced potency and incomplete neutralization of broadly neutralizing antibodies against cell-to-cell transmission of HIV-1 with transmitted founder Envs","volume":"91","author":"Li","year":"2017","journal-title":"J Virol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"7813","DOI":"10.1128\/JVI.00783-15","article-title":"Inhibitory effect of individual or combinations of broadly neutralizing antibodies and antiviral reagents against cell-free and cell-to-cell HIV-1 transmission","volume":"89","author":"Gombos","year":"2015","journal-title":"J Virol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"e53138","DOI":"10.1371\/journal.pone.0053138","article-title":"Cell-to-cell transmission can overcome multiple donor and target cell barriers imposed on cell-free HIV","volume":"8","author":"Zhong","year":"2013","journal-title":"PLoS One"},{"key":"B65","doi-asserted-by":"publisher","first-page":"2813","DOI":"10.1084\/jem.20131244","article-title":"Broadly neutralizing antibodies that inhibit HIV-1 cell to cell transmission","volume":"210","author":"Malbec","year":"2013","journal-title":"J Exp Med"},{"key":"B66","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1093\/infdis\/jis183","article-title":"Transmembrane domain membrane proximal external region but not surface unit-directed broadly neutralizing HIV-1 antibodies can restrict dendritic cell-mediated HIV-1 trans-infection","volume":"205","author":"Sagar","year":"2012","journal-title":"J Infect Dis"},{"key":"B67","doi-asserted-by":"publisher","first-page":"7484","DOI":"10.1128\/JVI.00230-12","article-title":"Neutralization resistance of virological synapse-mediated HIV-1 infection is regulated by the gp41 cytoplasmic tail","volume":"86","author":"Durham","year":"2012","journal-title":"J Virol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"e1002634","DOI":"10.1371\/journal.ppat.1002634","article-title":"Cell-cell transmission enables HIV-1 to evade inhibition by potent CD4bs directed antibodies","volume":"8","author":"Abela","year":"2012","journal-title":"PLoS Pathog"},{"key":"B69","doi-asserted-by":"publisher","first-page":"5250","DOI":"10.1016\/j.vaccine.2011.05.016","article-title":"A cell-to-cell HIV transfer assay identifies humoral responses with broad neutralization activity","volume":"29","author":"Sanchez-Palomino","year":"2011","journal-title":"Vaccine"},{"key":"B70","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.chom.2011.10.015","article-title":"Cell-to-cell transfer of HIV-1 via virological synapses leads to endosomal virion maturation that activates Viral membrane fusion","volume":"10","author":"Dale","year":"2011","journal-title":"Cell Host Microbe"},{"key":"B71","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1126\/science.1167525","article-title":"Quantitative 3D video microscopy of HIV transfer across T cell virological synapses","volume":"323","author":"Hubner","year":"2009","journal-title":"Science"},{"key":"B72","doi-asserted-by":"publisher","first-page":"12582","DOI":"10.1128\/JVI.00381-07","article-title":"Predominant mode of human immunodeficiency virus transfer between T cells is mediated by sustained Env-dependent neutralization-resistant virological synapses","volume":"81","author":"Chen","year":"2007","journal-title":"J Virol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"3516","DOI":"10.1128\/JVI.02651-09","article-title":"Virological synapse-mediated spread of human immunodeficiency virus type 1 between T cells is sensitive to entry inhibition","volume":"84","author":"Martin","year":"2010","journal-title":"J Virol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1128\/JVI.03245-13","article-title":"High-multiplicity HIV-1 infection and neutralizing antibody evasion mediated by the macrophage-T cell virological synapse","volume":"88","author":"Duncan","year":"2014","journal-title":"J Virol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1097\/QAD.0b013e3283632ec4","article-title":"High multiplicity HIV-1 cell-to-cell transmission from macrophages to CD4+ T cells limits antiretroviral efficacy","volume":"27","author":"Duncan","year":"2013","journal-title":"AIDS"},{"key":"B76","doi-asserted-by":"publisher","first-page":"7840","DOI":"10.4049\/jimmunol.178.12.7840","article-title":"IgG opsonization of HIV impedes provirus formation in and infection of dendritic cells and subsequent long-term transfer to T cells","volume":"178","author":"Wilflingseder","year":"2007","journal-title":"J Immunol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1111\/imm.12016","article-title":"Specific antibody-dependent cellular cytotoxicity responses associated with slow progression of HIV infection","volume":"138","author":"Wren","year":"2013","journal-title":"Immunology"},{"key":"B78","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1089\/vim.2010.0108","article-title":"Activation of NK cells by ADCC responses during early HIV infection","volume":"24","author":"Chung","year":"2011","journal-title":"Viral Immunol"},{"key":"B79","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.4049\/jimmunol.157.5.2168","article-title":"HIV-1 gp120-specific antibody-dependent cell-mediated cytotoxicity correlates with rate of disease progression","volume":"157","author":"Baum","year":"1996","journal-title":"J Immunol"},{"key":"B80","doi-asserted-by":"publisher","first-page":"228ra238","DOI":"10.1126\/scitranslmed.3007736","article-title":"Polyfunctional Fc-effector profiles mediated by IgG subclass selection distinguish RV144 and VAX003 vaccines","volume":"6","author":"Chung","year":"2014","journal-title":"Sci Transl Med"},{"key":"B81","doi-asserted-by":"publisher","first-page":"12655","DOI":"10.1038\/s41598-017-12883-6","article-title":"Non-neutralizing antibodies targeting the V1V2 domain of HIV exhibit strong antibody-dependent cell-mediated cytotoxic activity","volume":"7","author":"Mayr","year":"2017","journal-title":"Sci Rep"},{"key":"B82","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1097\/COH.0000000000000319","article-title":"The first 24\u2009h: targeting the window of opportunity for antibody-mediated protection against HIV-1 transmission","volume":"11","author":"Lewis","year":"2016","journal-title":"Curr Opin HIV AIDS"},{"key":"B83","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2174\/1570162X13666150827093449","article-title":"Role of HIV-1 envelope glycoproteins conformation and accessory proteins on ADCC responses","volume":"14","author":"Veillette","year":"2016","journal-title":"Curr HIV Res"},{"key":"B84","doi-asserted-by":"publisher","first-page":"36685","DOI":"10.1038\/srep36685","article-title":"Molecular basis for epitope recognition by non-neutralizing anti-gp41 antibody F240","volume":"6","author":"Gohain","year":"2016","journal-title":"Sci Rep"},{"key":"B85","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/nature21710","article-title":"CD32a is a marker of a CD4 T-cell HIV reservoir harbouring replication-competent proviruses","volume":"543","author":"Descours","year":"2017","journal-title":"Nature"},{"key":"B86","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/1479-5876-11-193","article-title":"Fc-gamma receptor polymorphisms as predictive and prognostic factors in patients receiving oncolytic adenovirus treatment","volume":"11","author":"Hirvinen","year":"2013","journal-title":"J Transl Med"},{"key":"B87","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00281-017-0644-y","article-title":"Complement as a regulator of adaptive immunity","author":"Killick","year":"2017","journal-title":"Semin Immunopathol"},{"key":"B88","doi-asserted-by":"publisher","first-page":"2840","DOI":"10.12688\/f1000research.10065.1","article-title":"The complement system: an evolution in progress","volume":"5","author":"Ghebrehiwet","year":"2016","journal-title":"F1000Res"},{"key":"B89","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1556\/EuJMI.2.2012.2.2","article-title":"The complement system: history, pathways, cascade and inhibitors","volume":"2","author":"Nesargikar","year":"2012","journal-title":"Eur J Microbiol Immunol (Bp)"},{"key":"B90","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1038\/ni1113","article-title":"The complement system in regulation of adaptive immunity","volume":"5","author":"Carroll","year":"2004","journal-title":"Nat Immunol"},{"key":"B91","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/imr.12472","article-title":"The \u201cins and outs\u201d of complement-driven immune responses","volume":"274","author":"Freeley","year":"2016","journal-title":"Immunol Rev"},{"key":"B92","doi-asserted-by":"crossref","first-page":"6028","DOI":"10.4049\/jimmunol.152.12.6028","article-title":"Complement activation by recombinant HIV-1 glycoprotein gp120","volume":"152","author":"Susal","year":"1994","journal-title":"J Immunol"},{"key":"B93","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/0165-2478(89)90180-6","article-title":"HIV and HIV-infected cells differentially activate the human complement system independent of antibody","volume":"22","author":"Solder","year":"1989","journal-title":"Immunol Lett"},{"key":"B94","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1097\/COH.0000000000000058","article-title":"Complement and the control of HIV infection: an evolving story","volume":"9","author":"Frank","year":"2014","journal-title":"Curr Opin HIV AIDS"},{"key":"B95","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/cmi.2010.8","article-title":"The good and evil of complement activation in HIV-1 infection","volume":"7","author":"Yu","year":"2010","journal-title":"Cell Mol Immunol"},{"key":"B96","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.molimm.2004.06.024","article-title":"Complement-opsonized HIV: the free rider on its way to infection","volume":"42","author":"Stoiber","year":"2005","journal-title":"Mol Immunol"},{"key":"B97","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1006\/viro.1994.1622","article-title":"Complement control proteins, CD46, CD55, and CD59, as common surface constituents of human and simian immunodeficiency viruses and possible targets for vaccine protection","volume":"205","author":"Montefiori","year":"1994","journal-title":"Virology"},{"key":"B98","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1742-4690-8-16","article-title":"Extensive complement-dependent enhancement of HIV-1 by autologous non-neutralising antibodies at early stages of infection","volume":"8","author":"Willey","year":"2011","journal-title":"Retrovirology"},{"key":"B99","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1093\/infdis\/173.1.60","article-title":"Neutralizing and infection-enhancing antibody responses to human immunodeficiency virus type 1 in long-term nonprogressors","volume":"173","author":"Montefiori","year":"1996","journal-title":"J Infect Dis"},{"key":"B100","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1097\/00002030-199405000-00005","article-title":"Neutralizing and enhancing antibodies measured in complement-restored serum samples from HIV-1-infected individuals correlate with immunosuppression and disease","volume":"8","author":"Fust","year":"1994","journal-title":"AIDS"},{"key":"B101","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.imlet.2004.11.007","article-title":"HIV and human complement: inefficient virolysis and effective adherence","volume":"97","author":"Banki","year":"2005","journal-title":"Immunol Lett"},{"key":"B102","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/0042-6822(90)90449-2","article-title":"Complement-mediated antibody-dependent enhancement of HIV-1 infection requires CD4 and complement receptors","volume":"175","author":"Robinson","year":"1990","journal-title":"Virology"},{"key":"B103","first-page":"33","article-title":"Complement-mediated, antibody-dependent enhancement of HIV-1 infection in vitro is characterized by increased protein and RNA syntheses and infectious virus release","volume":"2","author":"Robinson","year":"1989","journal-title":"J Acquir Immune Defic Syndr"},{"key":"B104","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/S0140-6736(88)91657-1","article-title":"Antibody-dependent enhancement of human immunodeficiency virus type 1 infection","volume":"1","author":"Robinson","year":"1988","journal-title":"Lancet"},{"key":"B105","doi-asserted-by":"publisher","first-page":"e0180720","DOI":"10.1371\/journal.pone.0180720","article-title":"V1V2-specific complement activating serum IgG as a correlate of reduced HIV-1 infection risk in RV144","volume":"12","author":"Perez","year":"2017","journal-title":"PLoS One"},{"key":"B106","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.ebiom.2017.05.029","article-title":"HIV-specific B cell frequency correlates with neutralization breadth in patients naturally controlling HIV-infection","volume":"21","author":"Rouers","year":"2017","journal-title":"EBioMedicine"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2017.01590\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T18:54:03Z","timestamp":1693248843000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2017.01590\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,20]]},"references-count":106,"alternative-id":["10.3389\/fimmu.2017.01590"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2017.01590","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,20]]},"article-number":"1590"}}